{"id":28910,"date":"2021-11-24T16:00:59","date_gmt":"2021-11-24T15:00:59","guid":{"rendered":"https:\/\/www.satt.fr\/creation-de-la-startup-brightsens-diagnostics-conectus\/"},"modified":"2021-11-24T16:00:59","modified_gmt":"2021-11-24T15:00:59","slug":"creation-de-la-startup-brightsens-diagnostics-conectus","status":"publish","type":"post","link":"https:\/\/www.satt.fr\/en\/creation-de-la-startup-brightsens-diagnostics-conectus\/","title":{"rendered":"Cr\u00e9ation de la startup BrightSens Diagnostics (Conectus)"},"content":{"rendered":"<p><span style=\"color: #c90f4c;\"><strong>\u00c9tablie \u00e0 Strasbourg, la startup BrightSens Diagnostics, incub\u00e9e chez SEMIA et jeune laur\u00e9ate du Concours d\u2019Innovation I-Lab 2021, d\u00e9veloppe une technologie de rupture dans le diagnostic mol\u00e9culaire. Son innovation, issue du Laboratoire de Bioimagerie et Pathologies (UMR CNRS 7021 \/ Universit\u00e9 de Strasbourg) a \u00e9t\u00e9 propuls\u00e9e par la SATT Conectus. Elle permettra de faciliter et d\u2019acc\u00e9l\u00e9rer la d\u00e9tection de maladies et d\u2019optimiser le suivi des patients. A la cl\u00e9 : des tests de d\u00e9pistage et de diagnostic pr\u00e9coce simples, rapides, \u00e9conomiques et \u00e9cologiques, avec deux premi\u00e8res voies d\u2019applications en oncologie et virologie.<br \/><\/strong><\/span><br \/>En particulier en mati\u00e8re de cancer, plus on diagnostique t\u00f4t, meilleures sont les chances de gu\u00e9rison et de survie. Un <strong>d\u00e9pistage pr\u00e9coce<\/strong> peut faire toute la diff\u00e9rence et sauver des vies. <strong>Un d\u00e9pistage efficace n\u00e9cessite une tr\u00e8s grande sensibilit\u00e9 afin de d\u00e9tecter la maladie \u00e0 un stade pr\u00e9coce mais aussi un test diagnostic facile d\u2019utilisation et \u00e0 faible co\u00fbt pour permettre le d\u00e9pistage de masse.<\/strong><\/p>\n<p><strong><span style=\"color: #c90f4c;\">Capter des biomarqueurs canc\u00e9reux \u00e0 un stade plus pr\u00e9coce<\/span><\/strong><\/p>\n<p><strong>BrightSens Diagnostics d\u00e9veloppe une nouvelle g\u00e9n\u00e9ration de tests de diagnostic mol\u00e9culaire<\/strong> en Point of Care qui r\u00e9pond \u00e0 cette attente. Ses tests reposent sur une technologie in\u00e9dite bas\u00e9e sur des nanoparticules aux caract\u00e9ristiques uniques. Fluorescentes, ultra-lumineuses, ultra-sensibles, elles permettent d\u2019amplifier le signal de d\u00e9tection et ainsi de mesurer de tr\u00e8s faibles concentrations d\u2019ADN\/ARN (biomarqueurs-cl\u00e9s des maladies) par simple mesure de fluorescence, sans l\u2019utilisation d\u2019instruments co\u00fbteux tel que la PCR.<\/p>\n<p><span style=\"color: #c90f4c;\">Les points forts de cette technologie innovante sont<\/span> :<\/p>\n<ul>\n<li><strong>Rapidit\u00e9 et ultra sensibilit\u00e9 :<\/strong> r\u00e9sultats quantitatifs en quelques minutes<\/li>\n<li><strong>Simplicit\u00e9 et facilit\u00e9 d&#8217;utilisation :<\/strong> sans PCR et non invasif<\/li>\n<li><strong>Adaptabilit\u00e9 :<\/strong> technologie adaptable selon les cibles recherch\u00e9es, quantitative avec possibilit\u00e9 de multiplexage, petits instruments de lecture et smartphones<\/li>\n<li><strong>Economiques :<\/strong> impact m\u00e9dico-\u00e9conomique fort = meilleure pr\u00e9vention et suivi du patient, aucun besoin d\u2019instruments co\u00fbteux ni de personnel qualifi\u00e9<\/li>\n<li><strong>Ecologiques :<\/strong> beaucoup moins consommateurs de r\u00e9actifs que la PCR, ne contient pas de mat\u00e9riaux dangereux<\/li>\n<\/ul>\n<div id=\"attachment_28286\" style=\"width: 310px\" class=\"wp-caption alignright\"><img loading=\"lazy\" decoding=\"async\" aria-describedby=\"caption-attachment-28286\" class=\"size-medium wp-image-28286\" src=\"https:\/\/www.satt.fr\/wp-content\/uploads\/2021\/11\/3-co-fondateurs_BD-300x156.jpg\" alt=\"Les 3 co fondateurs de BrightSens Diagnostics\" width=\"300\" height=\"156\" srcset=\"https:\/\/www.satt.fr\/wp-content\/uploads\/2021\/11\/3-co-fondateurs_BD-300x156.jpg 300w, https:\/\/www.satt.fr\/wp-content\/uploads\/2021\/11\/3-co-fondateurs_BD-1024x531.jpg 1024w, https:\/\/www.satt.fr\/wp-content\/uploads\/2021\/11\/3-co-fondateurs_BD-150x78.jpg 150w, https:\/\/www.satt.fr\/wp-content\/uploads\/2021\/11\/3-co-fondateurs_BD-768x398.jpg 768w, https:\/\/www.satt.fr\/wp-content\/uploads\/2021\/11\/3-co-fondateurs_BD-1536x796.jpg 1536w, https:\/\/www.satt.fr\/wp-content\/uploads\/2021\/11\/3-co-fondateurs_BD-500x259.jpg 500w, https:\/\/www.satt.fr\/wp-content\/uploads\/2021\/11\/3-co-fondateurs_BD-600x311.jpg 600w, https:\/\/www.satt.fr\/wp-content\/uploads\/2021\/11\/3-co-fondateurs_BD-193x100.jpg 193w, https:\/\/www.satt.fr\/wp-content\/uploads\/2021\/11\/3-co-fondateurs_BD.jpg 1541w\" sizes=\"auto, (max-width: 300px) 100vw, 300px\" \/><p id=\"caption-attachment-28286\" class=\"wp-caption-text\">Les 3 co-fondateurs de BrightSens Diagnostics,<br \/>de gauche \u00e0 droite : Andreas REISCH, John VOLKE, Andrey KLYMCHENKO I Copyright : Styl&#8217;List<\/p><\/div>\n<p>Il aura fallu pr\u00e8s de 7 ans de recherche soutenus \u00e0 hauteur de 2 M\u20ac par le prestigieux Conseil europ\u00e9en de la recherche (ERC) pour aboutir \u00e0 des premiers r\u00e9sultats, gr\u00e2ce \u00e0 la mobilisation d\u2019un tandem de chercheurs passionn\u00e9s, <strong>Dr. Andrey KLYMCHENKO, Directeur de Recherche CNRS, et les membres de son \u00e9quipe Nanochimie et Bioimagerie, notamment Dr. Andreas REISCH, Ma\u00eetre de conf\u00e9rences, au sein du Laboratoire de Bioimagerie et Pathologies (UMR CNRS 7021 \/ Universit\u00e9 de Strasbourg).<\/strong><\/p>\n<p>Les kits de d\u00e9tection de BrightSens permettront d\u2019analyser rapidement un grand nombre d\u2019\u00e9chantillons cliniques et d\u2019identifier au plus vite des biomarqueurs-cl\u00e9s, notamment dans les domaines strat\u00e9giques de l\u2019oncologie et de la virologie. A terme, ces nouveaux tests de diagnostic pourraient compl\u00e9ter, voire remplacer dans certains cas, la technologie phare du march\u00e9, la PCR.<\/p>\n<p>La jeune startup d\u00e9veloppe actuellement prioritairement des tests simples d\u2019utilisation et peu co\u00fbteux pour la d\u00e9tection du SARS-<strong>Cov 2 (Covid 19) et de ses variants<\/strong>. Elle se mobilise \u00e9galement activement dans le diagnostic pr\u00e9coce et le suivi de patients atteints des <strong>cancers (poumon, sein, colorectal, pancr\u00e9as).<\/strong><\/p>\n<ul>\n<li>Caroline Dreyer, Pr\u00e9sidente de la SATT Conectus : <em>\u00ab BrightSens Diagnostics, c\u2019est une aventure d\u2019hommes de l\u2019entrepreneuriat et de la science. Comme toujours dans la sant\u00e9, c\u2019est un pari intense, fait de vrais risques. Conectus a investi 500 k\u20ac pour optimiser la technologie et lui permettre d\u2019atteindre les performances requises pour une utilisation clinique. Gr\u00e2ce \u00e0 notre dispositif Team-to-market.fr, nous avons \u00e9galement pu identifier un CEO, John Volke, dont les comp\u00e9tences apr\u00e8s 18 ann\u00e9es d\u2019exp\u00e9rience dans le diagnostic in vitro lui ont permis de fixer le plan strat\u00e9gique parfaitement adapt\u00e9 au projet BrightSens. R\u00e9ussir le d\u00e9collage d\u2019une startup, c\u2019est un peu travailler en famille. A nous de savoir mobiliser au bon moment les bonnes ressources et partenaires de tout notre \u00e9cosyst\u00e8me territorial, qui, en Alsace, est particuli\u00e8rement efficient \u00bb.<\/em><\/li>\n<\/ul>\n<p><strong><span style=\"color: #c90f4c;\">Des distinctions et d\u00e9j\u00e0 2 partenaires cliniques majeurs<\/span><\/strong><\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"alignleft size-thumbnail wp-image-28289\" src=\"https:\/\/www.satt.fr\/wp-content\/uploads\/2021\/11\/BRIGHTSENS_logo-150x71.png\" alt=\"Logo BrightSens\" width=\"150\" height=\"71\" srcset=\"https:\/\/www.satt.fr\/wp-content\/uploads\/2021\/11\/BRIGHTSENS_logo-150x71.png 150w, https:\/\/www.satt.fr\/wp-content\/uploads\/2021\/11\/BRIGHTSENS_logo-300x142.png 300w, https:\/\/www.satt.fr\/wp-content\/uploads\/2021\/11\/BRIGHTSENS_logo-200x94.png 200w, https:\/\/www.satt.fr\/wp-content\/uploads\/2021\/11\/BRIGHTSENS_logo.png 500w\" sizes=\"auto, (max-width: 150px) 100vw, 150px\" \/>John VOLKE, CEO et cofondateur de BrightSens Diagnostics, m\u00e8ne tambour battant le d\u00e9collage de la startup : <em>\u00ab Tous les indicateurs sont au vert. Nous accumulons les distinctions et reconnaissances r\u00e9gionales et nationales. Cette ann\u00e9e, la R\u00e9gion Grand Est nous a ainsi accord\u00e9 son soutien dans le cadre du dispositif national i-Lab du Minist\u00e8re de l\u2019Enseignement sup\u00e9rieur, de la Recherche et de l\u2019Innovation financ\u00e9 par Bpifrance. Notre offre de tests r\u00e9pondra enti\u00e8rement aux probl\u00e9matiques m\u00e9dico-\u00e9conomiques actuelles et futures auxquelles tant les populations que les pouvoirs publics sont confront\u00e9s. Notre offre de d\u00e9tection de la Covid19 et de ses variants sera notre premi\u00e8re r\u00e9ponse en proposant une synth\u00e8se des performances des tests PCR \u00e0 un tarif proche des tests antig\u00e9niques. Les premiers contacts avec des \u00ab big pharma \u00bb sont nou\u00e9s et nous comptons d\u00e9j\u00e0 deux partenaires cliniques d\u2019envergure : l\u2019IRCAD pour le cancer colorectal et l\u2019ICANS pour le cancer du sein Bourse au porteur. Depuis juin dernier, nous sommes laur\u00e9ats du Concours d\u2019Innovation\u00bb.<\/em><\/p>\n<p><strong>Les kits de d\u00e9tection devraient \u00eatre sur le march\u00e9 d\u2019ici 2022-2023 et serviront prioritairement les h\u00f4pitaux, laboratoires d\u2019analyse m\u00e9dicale, les pharmacies, les centres de sant\u00e9, mais aussi plus largement tous les acteurs des technologies m\u00e9dicales.<\/strong> BrightSens Diagnostics devrait rapidement \u00e9toffer ses \u00e9quipes et rejoindre au courant du 3i\u00e8me trimestre 2022 de nouveaux locaux \u00e0 Strasbourg.<\/p>\n<p>&nbsp;<\/p>\n<p><a href=\"https:\/\/www.conectus.fr\/sites\/default\/files\/2021-11\/CP_CREATION%20STARTUP%20BRIGHTSENS_final.pdf\"><span style=\"font-size: 14pt;\"><strong><span style=\"color: #c90f4c;\">LIRE LE COMMUNIQUE DE PRESSE INTEGRAL<\/span><\/strong><\/span><\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>\u00c9tablie \u00e0 Strasbourg, la startup BrightSens Diagnostics, incub\u00e9e chez SEMIA et jeune laur\u00e9ate du Concours d\u2019Innovation I-Lab 2021, d\u00e9veloppe une technologie de rupture dans le diagnostic mol\u00e9culaire. Son innovation, issue du Laboratoire de Bioimagerie et Pathologies (UMR CNRS 7021 \/ Universit\u00e9 de Strasbourg) a \u00e9t\u00e9 propuls\u00e9e par la SATT Conectus. Elle permettra de faciliter et [&hellip;]<\/p>\n","protected":false},"author":7,"featured_media":28287,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[567,568,604],"tags":[],"class_list":["post-28910","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news-en","category-successstories-en","category-startup-en"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.2 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Cr\u00e9ation de la startup BrightSens Diagnostics (Conectus) - R\u00e9seau SATT<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.satt.fr\/en\/creation-de-la-startup-brightsens-diagnostics-conectus\/\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"France MANDRY\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"5 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.satt.fr\/en\/creation-de-la-startup-brightsens-diagnostics-conectus\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.satt.fr\/en\/creation-de-la-startup-brightsens-diagnostics-conectus\/\"},\"author\":{\"name\":\"France MANDRY\",\"@id\":\"https:\/\/www.satt.fr\/en\/#\/schema\/person\/3c07a164c17f01f656480221ba81ab4e\"},\"headline\":\"Cr\u00e9ation de la startup BrightSens Diagnostics (Conectus)\",\"datePublished\":\"2021-11-24T15:00:59+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.satt.fr\/en\/creation-de-la-startup-brightsens-diagnostics-conectus\/\"},\"wordCount\":985,\"image\":{\"@id\":\"https:\/\/www.satt.fr\/en\/creation-de-la-startup-brightsens-diagnostics-conectus\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.satt.fr\/wp-content\/uploads\/2021\/11\/3-co-fondateurs_BD.jpg\",\"articleSection\":[\"News\",\"Success Stories\",\"Start-up\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.satt.fr\/en\/creation-de-la-startup-brightsens-diagnostics-conectus\/\",\"url\":\"https:\/\/www.satt.fr\/en\/creation-de-la-startup-brightsens-diagnostics-conectus\/\",\"name\":\"Cr\u00e9ation de la startup BrightSens Diagnostics (Conectus) - R\u00e9seau SATT\",\"isPartOf\":{\"@id\":\"https:\/\/www.satt.fr\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.satt.fr\/en\/creation-de-la-startup-brightsens-diagnostics-conectus\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.satt.fr\/en\/creation-de-la-startup-brightsens-diagnostics-conectus\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.satt.fr\/wp-content\/uploads\/2021\/11\/3-co-fondateurs_BD.jpg\",\"datePublished\":\"2021-11-24T15:00:59+00:00\",\"author\":{\"@id\":\"https:\/\/www.satt.fr\/en\/#\/schema\/person\/3c07a164c17f01f656480221ba81ab4e\"},\"breadcrumb\":{\"@id\":\"https:\/\/www.satt.fr\/en\/creation-de-la-startup-brightsens-diagnostics-conectus\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.satt.fr\/en\/creation-de-la-startup-brightsens-diagnostics-conectus\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.satt.fr\/en\/creation-de-la-startup-brightsens-diagnostics-conectus\/#primaryimage\",\"url\":\"https:\/\/www.satt.fr\/wp-content\/uploads\/2021\/11\/3-co-fondateurs_BD.jpg\",\"contentUrl\":\"https:\/\/www.satt.fr\/wp-content\/uploads\/2021\/11\/3-co-fondateurs_BD.jpg\",\"width\":1541,\"height\":799},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.satt.fr\/en\/creation-de-la-startup-brightsens-diagnostics-conectus\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\/\/www.satt.fr\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Cr\u00e9ation de la startup BrightSens Diagnostics (Conectus)\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.satt.fr\/en\/#website\",\"url\":\"https:\/\/www.satt.fr\/en\/\",\"name\":\"R\u00e9seau SATT\",\"description\":\"Les Soci\u00e9t\u00e9s d&#039;Acc\u00e9l\u00e9ration du Transfert de Technologies\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.satt.fr\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.satt.fr\/en\/#\/schema\/person\/3c07a164c17f01f656480221ba81ab4e\",\"name\":\"France MANDRY\",\"url\":\"https:\/\/www.satt.fr\/en\/author\/france\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Cr\u00e9ation de la startup BrightSens Diagnostics (Conectus) - R\u00e9seau SATT","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.satt.fr\/en\/creation-de-la-startup-brightsens-diagnostics-conectus\/","twitter_misc":{"Written by":"France MANDRY","Est. reading time":"5 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.satt.fr\/en\/creation-de-la-startup-brightsens-diagnostics-conectus\/#article","isPartOf":{"@id":"https:\/\/www.satt.fr\/en\/creation-de-la-startup-brightsens-diagnostics-conectus\/"},"author":{"name":"France MANDRY","@id":"https:\/\/www.satt.fr\/en\/#\/schema\/person\/3c07a164c17f01f656480221ba81ab4e"},"headline":"Cr\u00e9ation de la startup BrightSens Diagnostics (Conectus)","datePublished":"2021-11-24T15:00:59+00:00","mainEntityOfPage":{"@id":"https:\/\/www.satt.fr\/en\/creation-de-la-startup-brightsens-diagnostics-conectus\/"},"wordCount":985,"image":{"@id":"https:\/\/www.satt.fr\/en\/creation-de-la-startup-brightsens-diagnostics-conectus\/#primaryimage"},"thumbnailUrl":"https:\/\/www.satt.fr\/wp-content\/uploads\/2021\/11\/3-co-fondateurs_BD.jpg","articleSection":["News","Success Stories","Start-up"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.satt.fr\/en\/creation-de-la-startup-brightsens-diagnostics-conectus\/","url":"https:\/\/www.satt.fr\/en\/creation-de-la-startup-brightsens-diagnostics-conectus\/","name":"Cr\u00e9ation de la startup BrightSens Diagnostics (Conectus) - R\u00e9seau SATT","isPartOf":{"@id":"https:\/\/www.satt.fr\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.satt.fr\/en\/creation-de-la-startup-brightsens-diagnostics-conectus\/#primaryimage"},"image":{"@id":"https:\/\/www.satt.fr\/en\/creation-de-la-startup-brightsens-diagnostics-conectus\/#primaryimage"},"thumbnailUrl":"https:\/\/www.satt.fr\/wp-content\/uploads\/2021\/11\/3-co-fondateurs_BD.jpg","datePublished":"2021-11-24T15:00:59+00:00","author":{"@id":"https:\/\/www.satt.fr\/en\/#\/schema\/person\/3c07a164c17f01f656480221ba81ab4e"},"breadcrumb":{"@id":"https:\/\/www.satt.fr\/en\/creation-de-la-startup-brightsens-diagnostics-conectus\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.satt.fr\/en\/creation-de-la-startup-brightsens-diagnostics-conectus\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.satt.fr\/en\/creation-de-la-startup-brightsens-diagnostics-conectus\/#primaryimage","url":"https:\/\/www.satt.fr\/wp-content\/uploads\/2021\/11\/3-co-fondateurs_BD.jpg","contentUrl":"https:\/\/www.satt.fr\/wp-content\/uploads\/2021\/11\/3-co-fondateurs_BD.jpg","width":1541,"height":799},{"@type":"BreadcrumbList","@id":"https:\/\/www.satt.fr\/en\/creation-de-la-startup-brightsens-diagnostics-conectus\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/www.satt.fr\/en\/"},{"@type":"ListItem","position":2,"name":"Cr\u00e9ation de la startup BrightSens Diagnostics (Conectus)"}]},{"@type":"WebSite","@id":"https:\/\/www.satt.fr\/en\/#website","url":"https:\/\/www.satt.fr\/en\/","name":"R\u00e9seau SATT","description":"Les Soci\u00e9t\u00e9s d&#039;Acc\u00e9l\u00e9ration du Transfert de Technologies","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.satt.fr\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.satt.fr\/en\/#\/schema\/person\/3c07a164c17f01f656480221ba81ab4e","name":"France MANDRY","url":"https:\/\/www.satt.fr\/en\/author\/france\/"}]}},"_links":{"self":[{"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/posts\/28910","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/comments?post=28910"}],"version-history":[{"count":0,"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/posts\/28910\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/media\/28287"}],"wp:attachment":[{"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/media?parent=28910"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/categories?post=28910"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/tags?post=28910"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}